Song Shijun, professor, chief physician, CPC member, has been engaged in clinical work of oncology fo...
Peng Xiaochi, M.D., Ph.D. graduate in Canada, is a member of the Chinese Medical Association, the B...
She specializes in various minimally invasive treatments for tumors, especially chemotherapy, targete...
Ma Xiaoying, more than 20 years experience of clinical work in oncology, and is currently a member...
Dr. Lin Jing has been engaged in clinical work in oncology for nearly 20 years and is currently a mem...
Prostate cancerMr.Chen was diagnosed prostate cancer, the local doctor suggested him to undergo a direct resection, ...
Rectal cancerCHAN KHIAN YAP, 35 years old, from Malaysia. He was diagnosed with rectal cancer in 2022 and refused ...
Breast CancerNoraini, from Malaysia, was diagnosed with stage IIIB breast cancer accompanied by lymph node metasta...
Views：183
2024-09-24
Share
DEB-TACE are the most advanced embolic material currently used in international clinical interventions. What are the upgrades of DEB-TACE on the basis of traditional interventional therapy? Dr Peng Xiaochi, Director of Oncology Department of St. Stamford Modern Cancer Hospital Guangzhou, will explain it to you.
(MY)+60 10-898 8919
Language
